Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $9.57B.
ENTERPRISE VALUE (EV)
$9.57B
Vaxcyte, Inc.
Market Cap
$9.63B
Enterprise Value (EV)
$9.57B
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Vaxcyte, Inc. (PCVX) | $9.63B | $9.57B |
| Krystal Biotech, Inc. (KRYS)vs › | $9.63B | $9.22B |
| Henry Schein, Inc. (HSIC)vs › | $9.66B | $13.32B |
| Repligen Corporation (RGEN)vs › | $9.87B | $9.95B |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $9.93B | $10.61B |
| Insulet Corp. (PODD)vs › | $9.33B | $9.75B |
| The Ensign Group, Inc. (ENSG)vs › | $10.03B | $12.02B |
| Bruker Corporation (BRKR)vs › | $9.21B | $10.94B |
| Align Technology, Inc. (ALGN)vs › | $10.13B | $9.15B |
| ImmunityBio, Inc. (IBRX)vs › | $10.15B | $10.89B |
Market Cap
$9.63B
Total Debt
$117.48M
Cash
$173.96M
Enterprise Value
$9.57B
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
